Tag: X

BOCA RATON, FL, June 16, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced its support for the launch of a new dfdvSOL / SOL liquidity pool on Orca, one of the leading Solana-native decentralized exchanges. The pool, deployed on Orca’s flagship Concentrated Liquidity Market Maker (CLMM), introduces new utility and yield opportunities for dfdvSOL holders, while contributing to long-term growth in SOL per share (SPS).

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retinopathies). The FDA previously granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation for OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa 19, and cone-rod dystrophy 3.

빅토리아, 세이셸, June 16, 2025 (GLOBE NEWSWIRE) --   6월 5일부터 7일까지 베트남 다낭에서 개최된 솔라나 APAC 서밋 2025 (Solana APAC Summit 2025) 행사에서 비수탁형 Web3 지갑인 Bitget Wallet이 영향력 있는 시연 행사를 마무리했다. 이 서밋의 주요 스폰서 자격으로 참가한 Bitget Wallet은 3일간 진행된 이번 행사에서 최신 결제 기능을 선보이는 한편, 솔라나 생태계 전반의 빌더들과 교류하며, 온체인 도구가 아시아를 비롯한 전 세계의 실제 사용 사례를 어떻게 지원할 수 있는지 시연 무대를 가졌다.

빅토리아, 세이셸, June 16, 2025 (GLOBE NEWSWIRE) -- 비수탁형 웹3.0 지갑인 Bitget Wallet이 6월 10일부터 11일까지 마닐라 SMX 컨벤션 센터 (SMX Convention Center Manila)에서 열린 필리핀 블록체인 위크 (Philippines Blockchain Week)에 참가해 성공적으로 행사를 마무리했다. Bitget Wallet은 이번 참가를 통해 동남아시아에서 블록체인 접근성과 혁신을 주도하기 위한 노력을 더욱 강화하는 계기를 마련했다.

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Civitas Resources, Inc. (“Civitas” or “the Company”) (NYSE: CIVI) and certain of its officers.

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ibotta, Inc. (“Ibotta” or “the Company”) (NYSE: IBTA) and certain of its officers.

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe jamais présentée